[Correspondence] Lessons from the SPS3 trial

We read with interest the results of the SPS3 trial (Aug 10, p 507). The SPS3 Study Group concluded that the use of a systolic-blood-pressure (SBP) target of less than 130 mm Hg is likely to be beneficial for patients with recent lacunar stroke. However, several comments should be made before we encourage clinicians to achieve more intensive blood pressure reduction.

Source: LANCET - February 8, 2014 Category: Journals (General) Authors: Luis Castilla-Guerra, María del Carmen Fernandez-Moreno Tags: Correspondence Source Type: research